Time to reconsider risk for psychosis?

This scientific commentary refers to ‘Biosignatures of cognitive basic symptoms mark a distinct neurodevelopmental pathway to schizophrenia’ by Koutsouleris et al. (https://doi.org/10.1093/brain/awag100).

Authors

Stefan Kaiser
Matthias Kirschner

Institutions

Synopsys (Switzerland) (CH)
Geneva College (US)

Publication Details

Journal: Brain
Published: 2026-06-30
DOI: https://doi.org/10.1093/brain/awag230
Primary Topic: Schizophrenia research and treatment
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Time to reconsider risk for psychosis?

Stefan Kaiser, Matthias Kirschner

Jun 30, 2026

Brain

Schizophrenia research and treatment

article

Time to reconsider risk for psychosis?

Stefan Kaiser, Matthias Kirschner

June 30, 2026article en

Abstract

Brain

Synopsys (Switzerland) (CH), Geneva College (US)

Openalex Percentile: Top 7%

Schizophrenia research and treatment

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.